A54-year-old man withtype-2diabetes and dyslipidaemia has been prescribed metformin,piogitazone,
quiclazide.simvastatin andfenofbrate.
Which ofthefotlowingdruqshas predominantly peroxisome proliferator-activatedreceptor d (PPAR-a)
activity?
Fenofibrate
Guiclazide
Metformin
Pioqlitazone
Simvastatin
@1MINNDOCRINE
